“Liraglutide Ameliorates Metabolic Dysfunction Targeting the NRF2 Pathway in Obese Rats Induced by a High-Fat Diet” (2026) Al Mustansiriyah Journal of Pharmaceutical Sciences, 26(1), pp. 50–65. doi:10.32947/ajps.v26i1.1354.